Industry partnership critical for heart research
Professor Prash Sanders with Bradley Watson of Medtronic
Working across the 成人大片 and聽Royal Adelaide Hospital,聽Professor Prash Sanders聽leads a team of researchers聽and clinicians developing聽innovative solutions for the聽diagnosis and treatment聽of atrial fibrillation (AF).
Atrial fibrillation is a type of heart rhythm disorder聽which affects thousands of Australians, causing聽a fast and irregular heartbeat that can eventually聽lead to a stroke. Research from Professor Sanders鈥櫬爐eam has shown that hospitalisations related to聽atrial fibrillation are steadily increasing 鈥 faster than聽other cardiovascular conditions like heart attacks.
鈥淲e鈥檝e shown that AF is becoming more聽prevalent in our communities, leading to more聽hospitalisations and more serious complications聽like stroke,鈥 explained聽 Professor Sanders.
鈥淲e need better ways of identifying and treating聽AF so we can keep people out of hospital聽and maintaining a high quality of life.鈥
The multi-disciplinary team at the Centre for聽Heart Rhythm Disorders study is at the forefront聽of developing new and innovative approaches聽for atrial fibrillation, performing research from the聽laboratory all the way through to clinical trials.聽This essential research ensures that cardiologists聽have access to the best possible treatments and聽management strategies for patients with AF.
Critical for this progress is support from聽industry partners like Medtronic, a leading聽healthcare technology company working聽to advance medical treatments for聽 many聽conditions, including heart rhythm disorders.
鈥淢edtronic is a mission-driven company and our聽corporate values closely align with the Centre for聽Heart Rhythm Disorders. Our mutual commitment聽to improving the lives of patients has been the聽foundation of our relationship for over a decade,鈥澛爏aid Bradley Watson, a representative of Medtronic.
鈥淲e鈥檝e brought a number of clinical trials to聽the 成人大片 through the Centre聽for Heart Rhythm Disorders, including the first聽in human implant of a聽 percutaneous injectable聽loop recorder in 2013, which provided an聽opportunity to better understand the capability聽of this technology in identifying episodes of atrial聽fibrillation and potential stroke prevention.鈥
Together, Professor Sanders鈥 team at the Centre聽for Heart Rhythm Disorders and Medtronic聽are creating new solutions for AF patients, and聽delivering insights into newly-developed technology聽to make it accessible to patients sooner.
This collaboration is essential for our group 鈥 Medtronic is an essential industry partner that allows us to progress our fundamental work and get solutions out to patients as soon as possible.鈥Professor Sanders